BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16612213)

  • 1. Performance on the Wisconsin Card Sorting Test in families of schizophrenia patients with different familial loadings.
    Lin SH; Liu CM; Hwang TJ; Hsieh MH; Hsiao PC; Faraone SV; Tsuang MT; Hwu HG; Chen WJ
    Schizophr Bull; 2013 May; 39(3):537-46. PubMed ID: 23196712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case for Returning to Multiplex Families for Further Understanding the Heritability of Schizophrenia: A Psychiatrist's Perspective.
    DeLisi LE
    Mol Neuropsychiatry; 2016 May; 2(1):15-9. PubMed ID: 27606317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Relationship between Disability and Disease Severity, Cognitive Functions, and Insight in Patients with Schizophrenia.
    Kaloğlu HA; Nazlı ŞB
    Clin Psychopharmacol Neurosci; 2024 May; 22(2):333-344. PubMed ID: 38627080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of polygenic risk and cognitive subtype on brain morphology in schizophrenia spectrum and bipolar disorders.
    Quidé Y; Watkeys OJ; Girshkin L; Kaur M; Carr VJ; Cairns MJ; Green MJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1205-1218. PubMed ID: 35792918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families.
    Zhang Z; Zhang R; Qin P; Tan L
    Neuropsychiatr Dis Treat; 2018; 14():3339-3348. PubMed ID: 30584307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Schizophrenia's Abnormal Cortical Neural Synchrony in Monkeys.
    Kusi M; Brooks G; Noakes J; Hasekiu E; Ingle Gonzalez JE
    J Neurosci; 2018 Aug; 38(34):7375-7377. PubMed ID: 30131423
    [No Abstract]   [Full Text] [Related]  

  • 7. Touchscreen-paradigm for mice reveals cross-species evidence for an antagonistic relationship of cognitive flexibility and stability.
    Richter SH; Vogel AS; Ueltzhöffer K; Muzzillo C; Vogt MA; Lankisch K; Armbruster-Genç DJ; Riva MA; Fiebach CJ; Gass P; Vollmayr B
    Front Behav Neurosci; 2014; 8():154. PubMed ID: 24834036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "To see or not to see: that is the question." The "Protection-Against-Schizophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognitive aberrations.
    Landgraf S; Osterheider M
    Front Psychol; 2013; 4():352. PubMed ID: 23847557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive remediation in schizophrenia.
    Kaneko Y; Keshavan M
    Clin Psychopharmacol Neurosci; 2012 Dec; 10(3):125-35. PubMed ID: 23430145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia.
    Roalf DR; Gur RC; Almasy L; Richard J; Gallagher RS; Prasad K; Wood J; Pogue-Geile MF; Nimgaonkar VL; Gur RE
    Schizophr Bull; 2013 Sep; 39(5):1008-17. PubMed ID: 22927671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief review on recent developments in animal models of schizophrenia.
    Trivedi MS; Jarbe T
    Indian J Pharmacol; 2011 Jul; 43(4):375-80. PubMed ID: 21844988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premorbid cognitive deficits in young relatives of schizophrenia patients.
    Keshavan MS; Kulkarni S; Bhojraj T; Francis A; Diwadkar V; Montrose DM; Seidman LJ; Sweeney J
    Front Hum Neurosci; 2010; 3():62. PubMed ID: 20300465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritability estimates for cognitive factors and brain white matter integrity as markers of schizophrenia.
    Bertisch H; Li D; Hoptman MJ; Delisi LE
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):885-94. PubMed ID: 20052692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive dysfunction in Turkish children at high risk for schizophrenia.
    Fis NP; Cetin FC; Erturk M; Erdogan E; Dedeoglu C; Yazgan Y
    Eur Child Adolesc Psychiatry; 2008 Oct; 17(7):424-31. PubMed ID: 18427864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
    Voss B; Thienel R; Leucht S; Kircher T
    Nervenarzt; 2008 Jan; 79(1):47-8, 50-2, 54-9. PubMed ID: 17960354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in the families of patients with schizophrenia.
    Heydebrand G
    Curr Opin Psychiatry; 2006 May; 19(3):277-81. PubMed ID: 16612213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial working memory deficits in schizophrenia patients and their first degree relatives from Palau, Micronesia.
    Myles-Worsley M; Park S
    Am J Med Genet; 2002 Aug; 114(6):609-15. PubMed ID: 12210274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.